Life Sciences
Regulonix, LLC
Year
2018
Regulonix is developing non-opioid-based small molecule inhibitors for chronic pain reduction. These molecules indirectly regulate voltage-gated sodium Nav1.7 channel via an unique pathway.
Website
Company Status
Active
U of A Inventors
Rajesh Khanna
May Khanna
Vijay Gokhale
Reena Chawla
Erik Dustrude
Todd Vanderah
College
College of Pharmacy, College of Medicine - Tucson, BIO5 Institute, UArizona Health Sciences, UArizona Cancer Center